IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: contrarian who wrote (1244)	9/9/1997 2:02:00 AM
From: Howard Hoffman	of 1762

The options deal takes a bit to figure out. I think that today the market figured that it is a very bullish stance by a savy company with very savy management. As a shareholder, I like it a lot. It means that IDEC will have lots of money to grow on before the cashflow from Rituxan starts flowing in (assuming that the stock continues to move up). With the growing recognition of the success story here, I expect IDPH to do better than most of us have thought. If the company ends up with a cover story in Fortune or Business Week, then where does the price go? Maybe, for once, IDPH will not sell on the actual news.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next